IRIX · NASDAQ
IRIDEX (IRIX) Stock Price & Fundamentals
IRIDEX (IRIX) closed at $803.27 on Oct 9, 2026, down 0.91% from the previous close of $810.64.
Share price, past year
1Y −3.12%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $803.27 |
| Sep 30, 2026 | $791.59 |
| Aug 31, 2026 | $791.60 |
| Jul 31, 2026 | $805.13 |
| Jun 30, 2026 | $838.42 |
| May 29, 2026 | $881.35 |
| Apr 30, 2026 | $888.05 |
| Mar 31, 2026 | $827.70 |
| Feb 27, 2026 | $816.18 |
| Jan 30, 2026 | $800.07 |
| Dec 31, 2025 | $799.59 |
| Nov 28, 2025 | $808.52 |
| Oct 31, 2025 | $836.64 |
Key statistics
- Market cap
- $14.02B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.20
- Revenue (TTM)
- $51.57M
- Net income (TTM)
- −$3.55M
- Shares outstanding
- 17.5M
- Dividend yield
- —
- 52-week range
- $778.28 – $913.35
IRIDEX's market cap is $14.02B, based on a share price of $803.27 and 17.5M shares outstanding as of Jul 4, 2026.
Financials
IRIDEX reported revenue of $52.68M for fiscal 2026.
IRIDEX reported a net loss of $4.44M in fiscal 2026.
IRIDEX's fiscal 2026 net loss was its first in at least 3 years.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2026ended Jan 3, 2026 | $52.68M | +8.2% | −$4.44M | −8.4% | −$0.26 | −$2.26M |
| FY2023ended Dec 28, 2024 | $48.67M | −6.2% | −$8.91M | −18.3% | −$0.54 | −$7.30M |
| FY2022ended Dec 30, 2023 | $51.87M | −9.0% | −$9.57M | −18.5% | −$0.59 | −$6.85M |
| FY2021ended Dec 31, 2022 | $56.97M | +5.7% | −$7.55M | −13.3% | −$0.47 | −$9.81M |
| FY2022ended Jan 1, 2022 | $53.90M | +48.3% | −$9.57M | −17.8% | −$0.59 | −$6.85M |
| FY2020ended Jan 2, 2021 | $36.35M | −16.3% | −$6.33M | −17.4% | −$0.46 | −$3.33M |
| FY2018ended Dec 28, 2019 | $43.45M | +2.0% | −$8.81M | −20.3% | −$0.64 | −$8.04M |
| FY2017ended Dec 29, 2018 | $42.60M | +2.4% | −$12.81M | −30.1% | −$1.05 | −$10.47M |
| FY2016ended Dec 30, 2017 | $41.59M | −9.9% | −$12.87M | −30.9% | −$1.11 | −$4.14M |
| FY2015ended Dec 31, 2016 | $46.16M | — | −$11.71M | −25.4% | −$1.15 | −$1.47M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2027ended Jul 4, 2026 | $12.57M | −$1.27M | −$0.07 |
| Q1 FY2027ended Apr 4, 2026 | $11.80M | −$524.00K | −$0.03 |
| Q4 FY2026ended Jan 3, 2026 | $14.72M | −$184.00K | −$0.01 |
| Q3 FY2026ended Sep 27, 2025 | $12.48M | −$1.57M | −$0.09 |
| Q2 FY2026ended Jun 28, 2025 | $13.57M | −$994.00K | −$0.06 |
| Q1 FY2026ended Mar 29, 2025 | $11.90M | −$1.69M | −$0.10 |
| Q4 FY2023ended Dec 28, 2024 | $12.70M | −$834.00K | — |
| Q3 FY2023ended Sep 28, 2024 | $11.58M | −$1.93M | −$0.12 |
Company profile
- Name
- IRIDEX Corporation
- Ticker
- IRIX
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Electromedical & Electrotherapeutic Apparatus
- Headquarters
- 1212 Terra Bella Ave, Mountain View, CA 94043
- Incorporated in
- DE
- Fiscal year ends
- January
- SEC CIK
- 0001006045
Recent SEC filings
- Sep 2, 2026
- Aug 18, 2026
- Aug 18, 2026
- Jul 16, 2026
- Jun 18, 2026
- May 19, 2026
- May 19, 2026
- Apr 2, 2026
Frequently asked questions
What is IRIDEX's stock price?
IRIDEX (IRIX) closed at $803.27 on Oct 9, 2026, down 0.91% from the previous close of $810.64.
What is IRIDEX's market cap?
IRIDEX's market cap is $14.02B, based on a share price of $803.27 and 17.5M shares outstanding as of Jul 4, 2026.
How much revenue does IRIDEX make?
IRIDEX reported revenue of $52.68M for fiscal 2026.
Does IRIDEX pay a dividend?
IRIDEX's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from IRIDEX Corporation's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures